{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:34:52Z","timestamp":1785803692112,"version":"3.56.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["HG200372-07"],"award-info":[{"award-number":["HG200372-07"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["1ZIADE000695"],"award-info":[{"award-number":["1ZIADE000695"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH\u201009\u20102\u20100128"],"award-info":[{"award-number":["W81XWH\u201009\u20102\u20100128"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10875-020-00817-3","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T04:53:42Z","timestamp":1594184022000},"page":"917-926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8880-3534","authenticated-orcid":false,"given":"Oskar","family":"Schnappauf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Sampaio","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K.","family":"Ombrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew G.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Deuitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyl","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hershfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Applegate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans T.","family":"Bjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Dane","family":"Witmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nara","family":"Sobreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Wohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Chiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"The American Genome","family":"Center","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton L.","family":"Dalgard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NIH Intramural Sequencing","family":"Center","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Kastner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivona","family":"Aksentijevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"issue":"10","key":"817_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370(10):911\u201320.","journal-title":"N Engl J Med"},{"issue":"10","key":"817_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370(10):921\u201331.","journal-title":"N Engl J Med"},{"issue":"5","key":"817_CR3","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1097\/MPH.0000000000000805","volume":"39","author":"H Hashem","year":"2017","unstructured":"Hashem H, Egler R, Dalal J. Refractory pure red cell aplasia manifesting as deficiency of adenosine deaminase 2. J Pediatr Hematol Oncol. 2017 Jul;39(5):e293\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"24","key":"817_CR4","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1182\/blood-2017-07-798660","volume":"130","author":"H Hashem","year":"2017","unstructured":"Hashem H, Kumar AR, Muller I, Babor F, Bredius R, Dalal J, et al. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood. 2017;130(24):2682\u20138.","journal-title":"Blood."},{"key":"817_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpeds.2016.06.058","volume":"177","author":"T Ben-Ami","year":"2016","unstructured":"Ben-Ami T, Revel-Vilk S, Brooks R, Shaag A, Hershfield MS, Kelly SJ, et al. Extending the clinical phenotype of adenosine deaminase 2 deficiency. J Pediatr. 2016;177:316\u201320.","journal-title":"J Pediatr"},{"issue":"3","key":"817_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10875-016-0245-x","volume":"36","author":"J Schepp","year":"2016","unstructured":"Schepp J, Bulashevska A, Mannhardt-Laakmann W, Cao H, Yang F, Seidl M, et al. Deficiency of adenosine deaminase 2 causes antibody deficiency. J Clin Immunol. 2016;36(3):179\u201386.","journal-title":"J Clin Immunol"},{"issue":"8","key":"817_CR7","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/art.40147","volume":"69","author":"J Schepp","year":"2017","unstructured":"Schepp J, Proietti M, Frede N, Buchta M, H\u00fcbscher K, Restrepo JR, et al. Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood. Arthritis Rheum. 2017;69(8):1689\u2013700.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"817_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3899\/jrheum.181384","volume":"47","author":"S \u00d6zen","year":"2020","unstructured":"\u00d6zen S, Batu ED, Ta\u015fk\u0131ran EZ, \u00d6zkara HA, \u00dcnal \u015e, G\u00fcleray N, et al. A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2. J Rheumatol. 2020;47(1):117\u201325.","journal-title":"J Rheumatol"},{"key":"817_CR9","doi-asserted-by":"crossref","unstructured":"Van Nieuwenhove E, Humblet-Baron S, Van Eyck L, De Somer L, Dooley J, Tousseyn T, et al. ADA2 deficiency mimicking idiopathic multicentric Castleman disease. Pediatrics. 2018;142(3).","DOI":"10.1542\/peds.2017-2266"},{"issue":"9","key":"817_CR10","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.39699","volume":"68","author":"S Nanthapisal","year":"2016","unstructured":"Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S, et al. Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases. Arthritis Rheum. 2016;68(9):2314\u201322.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"817_CR11","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","volume":"55","author":"JM Van Montfrans","year":"2016","unstructured":"Van Montfrans JM, Hartman EA, Braun KP, Hennekam EA, Hak EA, Nederkoorn PJ, et al. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations. Rheumatology (Oxford). 2016;55(5):902\u201310.","journal-title":"Rheumatology (Oxford)"},{"key":"817_CR12","doi-asserted-by":"crossref","unstructured":"Springer JM, Gierer SA, Jiang H, Kleiner D, Deuitch N, Ombrello AK, et al. Deficiency of adenosine deaminase 2 in adult siblings: many years of a misdiagnosed disease with severe consequences. Front Immunol. 2018;9(1361).","DOI":"10.3389\/fimmu.2018.01361"},{"issue":"8","key":"817_CR13","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3899\/jrheum.150024","volume":"42","author":"ED Batu","year":"2015","unstructured":"Batu ED, Karadag O, Taskiran EZ, Kalyoncu U, Aksentijevich I, Alikasifoglu M, et al. A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations. J Rheumatol. 2015;42(8):1532\u20134.","journal-title":"J Rheumatol"},{"issue":"6","key":"817_CR14","doi-asserted-by":"publisher","first-page":"a003384","DOI":"10.1101\/mcs.a003384","volume":"4","author":"D Claassen","year":"2018","unstructured":"Claassen D, Boals M, Bowling KM, Cooper GM, Cox J, Hershfield M, et al. Complexities of genetic diagnosis illustrated by an atypical case of congenital hypoplastic anemia. Cold Spring Harb Mol Case Stud. 2018;4(6):a003384.","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"10","key":"817_CR15","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","volume":"76","author":"R Caorsi","year":"2017","unstructured":"Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis. 2017;76(10):1648\u201356.","journal-title":"Ann Rheum Dis"},{"key":"817_CR16","unstructured":"Aksentijevich I, Moura NS, Barron K. Adenosine deaminase 2 deficiency. GeneReviews\u00ae[Internet]: University of Washington, Seattle; 2019."},{"key":"817_CR17","doi-asserted-by":"crossref","unstructured":"Gibson KM, Morishita KA, Dancey P, Moorehead P, Drogemoller B, Han X, et al. Identification of novel adenosine deaminase 2 gene variants and varied clinical phenotype in pediatric vasculitis. Arthritis & rheumatology (Hoboken, NJ). 2019.","DOI":"10.1002\/art.40913"},{"key":"817_CR18","doi-asserted-by":"crossref","unstructured":"Lee PY, Kellner ES, Huang Y, Furutani E, Huang Z, Bainter W, et al. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). J Allergy Clin Immunol. 2020;13.","DOI":"10.1016\/j.jaci.2019.12.908"},{"issue":"11","key":"817_CR19","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/bmt.2017.173","volume":"52","author":"H Hashem","year":"2017","unstructured":"Hashem H, Vatsayan A, Gupta A, Nagle K, Hershfield M, Dalal J. Successful reduced intensity hematopoietic cell transplant in a patient with deficiency of adenosine deaminase 2. Bone Marrow Transplant. 2017;52(11):1575\u20136.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"817_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaci.2014.10.010","volume":"135","author":"L Van Eyck Jr","year":"2015","unstructured":"Van Eyck L Jr, Hershfield MS, Pombal D, Kelly SJ, Ganson NJ, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135(1):283\u2013287.e285.","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 1","key":"817_CR21","doi-asserted-by":"publisher","first-page":"O40","DOI":"10.1186\/1546-0096-13-S1-O40","volume":"13","author":"A Ombrello","year":"2015","unstructured":"Ombrello A, Stone D, Hoffmann P, Jones A, Barham B, Barron K, et al. The deficiency of adenosine deaminase type 2-results of therapeutic intervention. Pediatr Rheumatol Online J. 2015;13(Suppl 1):O40.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"16","key":"817_CR22","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1056\/NEJMc1801927","volume":"380","author":"AK Ombrello","year":"2019","unstructured":"Ombrello AK, Qin J, Hoffmann PM, Kumar P, Stone D, Jones A, et al. Treatment strategies for deficiency of adenosine deaminase 2. N Engl J Med. 2019;380(16):1582\u20134.","journal-title":"N Engl J Med"},{"issue":"1","key":"817_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ng786","volume":"30","author":"GR Abecasis","year":"2002","unstructured":"Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet. 2002;30(1):97\u2013101.","journal-title":"Nat Genet"},{"issue":"6","key":"817_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41592-018-0001-7","volume":"15","author":"FJ Sedlazeck","year":"2018","unstructured":"Sedlazeck FJ, Rescheneder P, Smolka M, Fang H, Nattestad M, von Haeseler A, et al. Accurate detection of complex structural variations using single-molecule sequencing. Nat Methods. 2018;15(6):461\u20138.","journal-title":"Nat Methods"},{"key":"817_CR25","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv. 2019:531210."},{"issue":"8","key":"817_CR26","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s10875-019-00697-2","volume":"39","author":"HJ Chong-Neto","year":"2019","unstructured":"Chong-Neto HJ, Segundo GRS, Bandeira M, Chong-Silva DC, Ros\u00e1rio CS, Riedi CA, et al. Homozygous splice ADA2 gene mutation causing ADA-2 deficiency. J Clin Immunol. 2019;39(8):842\u20135.","journal-title":"J Clin Immunol"},{"issue":"4","key":"817_CR27","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.jaci.2018.01.012","volume":"141","author":"L Trotta","year":"2018","unstructured":"Trotta L, Martelius T, Siitonen T, Hautala T, Hamalainen S, Juntti H, et al. ADA2 deficiency: clonal lymphoproliferation in a subset of patients. J Allergy Clin Immunol. 2018;141(4):1534\u20131537.e1538.","journal-title":"J Allergy Clin Immunol"},{"key":"817_CR28","doi-asserted-by":"crossref","unstructured":"Alsultan A, Basher E, Alqanatish J, Mohammed R, Alfadhel M. Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis. Pediatr Blood Cancer. 2018;65(4).","DOI":"10.1002\/pbc.26912"},{"issue":"10","key":"817_CR29","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/nbt.1975","volume":"29","author":"MJ Clark","year":"2011","unstructured":"Clark MJ, Chen R, Lam HYK, Karczewski KJ, Chen R, Euskirchen G, et al. Performance comparison of exome DNA sequencing technologies. Nat Biotechnol. 2011;29(10):908\u201314.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"817_CR30","doi-asserted-by":"publisher","first-page":"12742","DOI":"10.1038\/srep12742","volume":"5","author":"D Shigemizu","year":"2015","unstructured":"Shigemizu D, Momozawa Y, Abe T, Morizono T, Boroevich KA, Takata S, et al. Performance comparison of four commercial human whole-exome capture platforms. Sci Rep. 2015;5(1):12742.","journal-title":"Sci Rep"},{"issue":"1","key":"817_CR31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/1471-2164-15-449","volume":"15","author":"CSR Chilamakuri","year":"2014","unstructured":"Chilamakuri CSR, Lorenz S, Madoui M-A, Vod\u00e1k D, Sun J, Hovig E, et al. Performance comparison of four exome capture systems for deep sequencing. BMC Genomics. 2014;15(1):449.","journal-title":"BMC Genomics"},{"issue":"9","key":"817_CR32","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1186\/gb-2011-12-9-r95","volume":"12","author":"XY Asan","year":"2011","unstructured":"Asan XY, Jiang H, Tyler-Smith C, Xue Y, Jiang T, et al. Comprehensive comparison of three commercial human whole-exome capture platforms. Genome Biol. 2011;12(9):R95.","journal-title":"Genome Biol"},{"issue":"6","key":"817_CR33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/cge.13518","volume":"95","author":"A Grossi","year":"2019","unstructured":"Grossi A, Cusano R, Rusmini M, Penco F, Schena F, Podda RA, et al. ADA2 deficiency due to a novel structural variation in 22q11.1. Clin Genet. 2019;95(6):732\u20133.","journal-title":"Clin Genet"},{"issue":"8","key":"817_CR34","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1101\/gr.229401.117","volume":"28","author":"X Song","year":"2018","unstructured":"Song X, Beck CR, Du R, Campbell IM, Coban-Akdemir Z, Gu S, et al. Predicting human genes susceptible to genomic instability associated with Alu\/Alu-mediated rearrangements. Genome Res. 2018;28(8):1228\u201342.","journal-title":"Genome Res"},{"issue":"10","key":"817_CR35","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tig.2015.05.010","volume":"31","author":"B Weckselblatt","year":"2015","unstructured":"Weckselblatt B, Rudd MK. Human structural variation: mechanisms of chromosome rearrangements. Trends Genet. 2015;31(10):587\u201399.","journal-title":"Trends Genet"},{"issue":"1","key":"817_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/gim.2011.7","volume":"14","author":"M Concei\u00e7\u00e3o Pereira","year":"2012","unstructured":"Concei\u00e7\u00e3o Pereira M, Loureiro JL, Pinto-Basto J, Brand\u00e3o E, Margarida Lopes A, Neves G, et al. Alu elements mediate large SPG11 gene rearrangements: further spatacsin mutations. Genetics in Medicine. 2012;14(1):143\u201351.","journal-title":"Genetics in Medicine"},{"issue":"1","key":"817_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1755-8417-1-4","volume":"1","author":"W Gu","year":"2008","unstructured":"Gu W, Zhang F, Lupski JR. Mechanisms for human genomic rearrangements. Pathogenetics. 2008;1(1):4\u20134.","journal-title":"Pathogenetics."},{"key":"817_CR38","unstructured":"Liebowitz J, Hellmann DB, Schnappauf O, et al. J Rheumatol. 2019; jrheum.180820."},{"key":"817_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13039-017-0333-5","volume":"10","author":"R Yao","year":"2017","unstructured":"Yao R, Zhang C, Yu T, Li N, Hu X, Wang X, et al. Evaluation of three read-depth based CNV detection tools using whole-exome sequencing data. Mol Cytogenet. 2017;10:30.","journal-title":"Mol Cytogenet"},{"issue":"9","key":"817_CR40","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41436-019-0475-4","volume":"21","author":"T Chiang","year":"2019","unstructured":"Chiang T, Liu X, Wu T-J, Hu J, Sedlazeck FJ, White S, et al. Atlas-CNV: a validated approach to call single-exon CNVs in the eMERGESeq gene panel. Genet Med. 2019;21(9):2135\u201344.","journal-title":"Genet Med"},{"issue":"6","key":"817_CR41","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1101\/gr.114876.110","volume":"21","author":"A Abyzov","year":"2011","unstructured":"Abyzov A, Urban AE, Snyder M, Gerstein M. CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. Genome Res. 2011 Jun;21(6):974\u201384.","journal-title":"Genome Res"},{"issue":"4","key":"817_CR42","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ajhg.2012.08.005","volume":"91","author":"M Fromer","year":"2012","unstructured":"Fromer M, Moran JL, Chambert K, Banks E, Bergen SE, Ruderfer DM, et al. Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. Am J Hum Genet. 2012;91(4):597\u2013607.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"817_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/ahg.12150","volume":"80","author":"AM Erzurumluoglu","year":"2016","unstructured":"Erzurumluoglu AM, Shihab HA, Rodriguez S, Gaunt TR, Day INM. Importance of genetic studies in consanguineous populations for the characterization of novel human gene functions. Ann Hum Genet. 2016;80(3):187\u201396.","journal-title":"Ann Hum Genet"},{"issue":"suppl 1","key":"817_CR44","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1073\/pnas.0906079106","volume":"107","author":"AH Bittles","year":"2010","unstructured":"Bittles AH, Black ML. Consanguinity, human evolution, and complex diseases. Proc Natl Acad Sci. 2010;107(suppl 1):1779\u201386.","journal-title":"Proc Natl Acad Sci"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00817-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-020-00817-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00817-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:20:05Z","timestamp":1625703605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-020-00817-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["817"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00817-3","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,8]]},"assertion":[{"value":"2 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}